EoCene subsidiary Colospan signs exclusive CG-100 distribution deal for Greece, Cyprus
EOCN•EoCene subsidiary Colospan signed its first European distribution agreement, granting Hospital Line exclusive rights to market, sell and distribute its CG-100 device in Greece and Cyprus, subject to commercial targets.
1. Distribution agreement
Colospan, Eocene's wholly owned subsidiary, signed an agreement with Hospital Line for exclusive CG-100 distribution in Greece and Cyprus, subject to mutually agreed commercial targets. Colospan plans to launch the device at the 17th Hellenic-Cypriot Surgical Conference while its US pivotal study is ongoing.
2. Device status
CG-100 is designed to reduce the need for diverting stomas. It is CE marked but not approved for commercial use in the United States.
